Found: 5
Select item for more details and to access through your institution.
Atezolizumab and stereotactic body radiotherapy in patients with advanced non‐small cell lung cancer: safety, clinical activity and ctDNA responses—the ComIT‐1 trial.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 3, p. 487, doi. 10.1002/1878-0261.13330
- By:
- Publication type:
- Article
Dynamic changes in the T cell receptor repertoire during treatment with radiotherapy combined with an immune checkpoint inhibitor.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 11, p. 2958, doi. 10.1002/1878-0261.13082
- By:
- Publication type:
- Article
The immune microenvironment in non‐small cell lung cancer is predictive of prognosis after surgery.
- Published in:
- Molecular Oncology, 2019, v. 13, n. 5, p. 1166, doi. 10.1002/1878-0261.12475
- By:
- Publication type:
- Article
Immune checkpoint blockade in the treatment of advanced non-small cell lung cancer – predictors of response and impact of previous radiotherapy.
- Published in:
- Acta Oncologica, 2021, v. 60, n. 2, p. 149, doi. 10.1080/0284186X.2020.1854851
- By:
- Publication type:
- Article
Protein Kinase C Isozymes Associated With Relapse Free Survival in Non-Small Cell Lung Cancer Patients.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.590755
- By:
- Publication type:
- Article